Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

456789101112

GSK commercial chief to become CEO at start of "pivotal" 2026

29th Sep 2025 09:09

(Alliance News) - GSK PLC Chief Executive Emma Walmsley will step down from the start of next year, the pharmaceutical firm announced Monday, with chief commercial officer Luke Miels named as its next boss. Read More

LONDON MARKET OPEN: FTSE 100 pushed higher by GSK and AstraZeneca

29th Sep 2025 09:02

(Alliance News) - Stock prices in London opened higher on Monday amid gains for GSK and AstraZeneca, while the gold price continued to climb. Read More

LONDON BRIEFING: AstraZeneca plans listing changes; GSK names next CEO

29th Sep 2025 07:53

(Alliance News) - AstraZeneca plans changes to its US listing and to retain its position in London, GSK promotes its chief commercial officer to lead the company while Merchants Trust raises its dividend. Read More

LONDON MARKET CLOSE: Brighter US outlook fires up European stocks

26th Sep 2025 17:11

(Alliance News) - The FTSE 100 recorded strong gains on Friday as US data pointed to resilient consumer spending and relatively subdued inflation, keeping hoped for rate cuts across the pond on track. Read More

LONDON MARKET CLOSE: Stocks struggle amid renewed bond market concern

25th Sep 2025 17:11

(Alliance News) - Stocks in London fell on Thursday and the pound dipped - while strong US data boosted the dollar - as talk of a political challenge to Keir Starmer saw UK bond yields climb. Read More

LONDON MARKET MIDDAY: Stocks lower after Trump u-turn on Ukraine

24th Sep 2025 12:03

(Alliance News) - London stocks were mixed at midday on Wednesday, following a Wall Street slump on Tuesday as investors digested US President Donald Trump's turnaround on the conflict in Ukraine. Read More

AstraZeneca and Daiichi's breast cancer drug wins US priority review

24th Sep 2025 10:55

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Wednesday said the US Food & Drug Administration has granted priority review for Enhertu in combination with pertuzumab as a first-line treatment for adults with HER2-positive metastatic breast cancer. Read More

LONDON MARKET CLOSE: Kingfisher flies but FTSE 100 loses early gains

23rd Sep 2025 17:11

(Alliance News) - Blue chips in London faded into the close on Tuesday, ending little changed, as worries over economic growth and inflation overshadowed strong results from Kingfisher. Read More

AstraZeneca says Tezspire and Koselugo recommended for approval in EU

22nd Sep 2025 08:39

(Alliance News) - AstraZeneca PLC on Monday said two drugs have been recommended for approval by the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More

LONDON BRIEFING: Wilmington profit declines; Elixirr earnings improve

22nd Sep 2025 07:58

(Alliance News) - London's FTSE is set to open lower on Monday, following a rate hold by China's central bank and the risk of heightened geopolitical tensions following the recognition of a Palestinian state by the UK, Australia, Canada and Portugal over the weekend. Read More

AstraZeneca says Ultomiris shows 3 years relapse-free in NMOSD

19th Sep 2025 08:24

(Alliance News) - AstraZeneca PLC on Friday said new long-term clinical trial data reinforce Ultomiris as a transformative treatment for neuromyelitis optica spectrum disorder, or NMOSD, a rare autoimmune disease that can cause blindness and paralysis. Read More

LONDON BROKER RATINGS: Deutsche Bank Research cuts Eurowag to 'hold'

17th Sep 2025 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca lupus drug succeeds in trial as COPD therapy fails

17th Sep 2025 09:06

(Alliance News) - AstraZeneca PLC on Wednesday reported mixed updates from its late-stage pipeline, with a lupus treatment hitting its main goal in a phase III trial, while a chronic obstructive pulmonary disease candidate fell short. Read More

UK and US strike tech deal as Trump arrives for state visit

17th Sep 2025 06:49

(Alliance News) - Britain and the US have struck a tech deal that could bring billions of pounds of investment to the UK as President Donald Trump arrived for his second state visit. Read More

LONDON MARKET CLOSE: FTSE 100 red ahead of expected US rate cut

15th Sep 2025 17:19

(Alliance News) - Stock prices in London closed mostly lower on Monday, as markets mainly price in an interest rate cut from the US Federal Reserve, and a hold from the Bank of England, this week. Read More

LONDON MARKET MIDDAY: FTSE 100 struggles but pound tops USD1.36

15th Sep 2025 12:06

(Alliance News) - Stock prices in Europe were largely on the up on Monday, though the FTSE 100 underwhelmed, while the dollar was on the decline ahead of an expected US Federal Reserve rate cut. Read More

Daiichi Sankyo advances EU application for tumour agnostic Enhertu

11th Sep 2025 10:11

(Alliance News) - Daiichi Sankyo Co Ltd on Thursday said the European Medicines Agency has validated the application for Enhertu to treat patients with a range of tumours. Read More

LONDON MARKET OPEN: Stocks climb before US inflation reading, ECB

11th Sep 2025 08:57

(Alliance News) - European stocks opened largely in the green on Thursday, as investors gear up for a US inflation reading and a European Central Bank decision. Read More

AstraZeneca says Tagrisso and chemotherapy deliver survival benefits

8th Sep 2025 01:18

(Alliance News) – AstraZeneca PLC said on Sunday that its Tagrisso lung cancer treatment plus chemotherapy delivered the longest survival benefits recorded in phase three trials. Read More

UK dividends calendar - next 7 days

1st Sep 2025 12:28

Read More

456789101112
FTSE 100 Latest
Value10,603.48
Change-5.40